Cancer naming conventions might be due for a revamp, according to Fabrice André, a medical oncologist and the upcoming president of the European Society...
Let’s talk about the pharmaceutical scene, where companies like Merck are making notable progress after the expiration of Keytruda’s patent. According to Merck’s CEO,...